ADDITIONAL ISSUANCE AGREEMENTAdditional Issuance Agreement • September 16th, 2016 • Propanc Health Group Corp • Pharmaceutical preparations
This Additional Issuance Agreement (this “Agreement”), dated as of September 13, 2016, is made pursuant to that certain Securities Purchase Agreement, dated as of October 28, 2015, as amended on March 11, 2016 by addendum and by letter agreement on July 1, 2016, and by letter agreement on August 3, 2016 (the “Purchase Agreement”), by and between Propanc Health Group Corporation, a Delaware corporation (the “Company”), and Delafield Investments Limited for the purchase of the Company’s 5% Original Issue Discount Senior Secured Convertible Debenture due February 28, 2017 (the “Debenture”) and the Common Stock purchase warrants issued and outstanding in connection therewith (collectively, the “Warrants”). Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
5% ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE DUE september 13, 2017Propanc Health Group Corp • September 16th, 2016 • Pharmaceutical preparations • New York
THIS 5% ORIGINAL ISSUE DISCOUNT SENIOR SECURED CONVERTIBLE DEBENTURE of PROPANC HEALTH GROUP CORPORATION, a Delaware corporation, (the “Company”), having its principal place of business at 302, 6 Butler Street, Camberwell, VIC, 3124 Australia, designated as its 5% Original Issue Discount Senior Secured Convertible Debenture due September 13, 2017 (the “Debenture”).
